title: An internist's update on cholesterol management.
abstract: Coronary heart disease (CHD) remains the leading cause of death in the United States. It is now well established that cholesterol is an important, reversible risk factor for CHD. This article provides a brief background on classification of the dyslipidemias, then discusses current recommendations for the evaluation and treatment of hyperlipidemia. Other risk factors currently being investigated as they relate to the development of CHD are discussed.
authors.affiliation: Department of Medicine, University of Mississippi Medical Center, Jackson 39216-4505, USA. hholman@medicine.umsmed.edu
authors.forename: Honey East
authors.initials: HE
authors.lastname: Holman
authors.forename: G Swink
authors.initials: GS
authors.lastname: Hicks
authors.forename: Annette K
authors.initials: AK
authors.lastname: Low
authors.forename: Marshall J
authors.initials: MJ
authors.lastname: Bouldin
authors.forename: Lori D
authors.initials: LD
authors.lastname: Russell
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Friedrich
authors.forename: C Andrew
authors.initials: CA
authors.lastname: Brown
mesh_terms: D000483:Alleles; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D015992:Body Mass Index; D002784:Cholesterol / Q000378:metabolism*; D003327:Coronary Disease / Q000517:prevention & control*; D006801:Humans; D006949:Hyperlipidemias / Q000145:classification / Q000628:therapy; D008077:Lipoproteins, LDL / Q000378:metabolism; D012307:Risk Factors
chemical_list: D000924:Anticholesteremic Agents; D008077:Lipoproteins, LDL; D002784:Cholesterol